Dermatological Reactions Associated With Anti-TNF Therapy in Inflammatory Bowel Disease: A Single-Centre, 13-Year Experience
Bibliographic record
Abstract
Introduction: Anti-TNF therapies are amongst our most effective therapies to induce and maintain remission in patients with inflammatory bowel disease (IBD). They are, however, not without side effects. Data on dermatological complications are limited. We describe the incidence, management and outcome of dermatological reactions associated with anti-TNF therapy in IBD patients at our centre. Methods: We conducted a retrospective review of 501 IBD patients treated with anti-TNF (Infliximab or Adalimumab) therapy between 2005-2018. Data was collected from electronic and paper-based case records and included disease demographics, clinical history, treatment and dermatological reactions Results: Fifty-four patients (10.7%) had dermatological reactions, 34 were female(63%). Forty two patients had Crohn's disease (CD=78%) and 12 had ulcerative colitis (UC =22.%). Montreal phenotype in CD was A2(30) L3(22) B1(25) and 7/10 UC patients had E3 disease. Mean age at diagnosis was 34.3 years (median 28, IQR 23.5) Thirty-eight patients were treated with Infliximab(IFX). A non-specific rash was noted in 14 patients, eczema in 10 and psoriasiform reactions in 9 patients.Six patients had shingles and urticaria, itching and acne were seen in 3 patients each. Seborrheic dermatitis, cellulitis and skin abscesses were noted in 2 patients each and 2 patients had Lichen planus and chicken pox. The average time of onset from treatment to symptoms was 20 months (median 7,IQR 27). In 20/ 38 patients treated with IFX, the dermatological reaction was mild, allowing continuation of treatment, 16 were switched to adalimumab (ADA) of which 3 patients had a recurrence (Psoriasis, itching and acne) leading to cessation of anti-TNF therapy and switch to Ustekinumab. One patient had no further biological treatment and another patient was switched to ustekinumab. Of 16 patients who had ADA, 13 continued treatment, 2 were switched to ustekinumab without any further reaction and in 1 patient no further biologic was administered. Conclusion: Ten percent of our anti-TNF treated patients had dermatological reaction. We did not observe a “class effect” after switching to a different anti TNF. Dermatological reactions were more common in colonic CD and with infliximab. Further studies on cumulative dermatological effects, risk factors, time to event and outcomes are underway at our institution.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.002 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".